Zofran is the brand name for the anti nausea medication (ondansetron hydrochloride) manufactured by British pharmaceutical giant GlaxoSmithKline. Since its approval by the U.S. Food and Drug Administration (FDA) in 1991, Zofran has been linked to a plethora of adverse side effects, including dizziness and lightheadedness. Dizziness and lightheadedness, in and of themselves are not …
Zofran (ondansetron hydrochloride) is a medication manufactured by the gigantic British pharmaceutical corporation GlaxoSmithKline and used to treat postoperative nausea and vomiting and chemotherapy-induced nausea and vomiting. It was approved by the U.S. Food and Drug Administration (FDA) in 1991 and has since been the subject of much controversy and a number of lawsuits. Zofran has …
The human body has a delicate chemical balance. Introducing or subtracting a chemical from that balance can cause side effects—both positive and negative. When your doctor prescribes a medication for you, they do so hoping that the side effects will be positive overall. Unfortunately, sometimes the negative side effects of a medication grossly outweigh the …
Zofran, pharmaceutical giant GlaxoSmithKline’s (GSK) brand name for the drug ondansetron, was approved by the U.S. Food and Drug Administration (FDA) in 1998. GlaxoSmithKline then began marketing Zofran as a remedy for morning sickness in pregnant women—a use for which the FDA had not approved the drug. The medication was then linked in studies to …
Zofran, the brand name for ondansetron, is a medication prescribed for people suffering from nausea. The drug was intended for use by cancer patients undergoing chemotherapy, but has become commonly prescribed to pregnant women experiencing morning sickness. Zofran was developed by GlaxoSmithKline during the 1980s and approved by the U.S. Food and Drug Administration (FDA) …
According to the American Diabetes Association, nearly 28 million Americans suffer from type 2 diabetes. This number is expected to grow as the population ages. The pharmaceutical industry sees this as a fertile marketplace for new type 2 diabetes medications. Among this new generation of drugs is Onglyza (saxagliptin), which was approved by the U.S. …
Xarelto, the brand name for rivaroxaban, is one of the newer anticoagulant medications, or blood thinners, on the market. It is commonly prescribed to prevent blood clots and protect people from strokes. Xarelto was developed by the German pharmaceutical giant Bayer AG, the company that once marketed heroin as a cough suppressant and non-addictive substitute …
A drug given to treat Parkinson’s disease and restless leg syndrome is the focus of a number of trials underway in the District Court of Minneapolis. More than 200 plaintiffs are taking their case forward in so-called bellwether jury trials to determine the stregnth and weakness of the cases. The cases have been consolidated against …
